Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma
@article{ATM112383, author = {Takuya Maeda and Teruki Yanagi and Hideyuki Ujiie}, title = {Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma}, journal = {Annals of Translational Medicine}, volume = {11}, number = {9}, year = {2023}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/112383} }